Clinical, Virological, and Pathological Profile of Patients Who Died of COVID-19: An Autopsy-Based Study From India

Jayanthi Yadav1, Garima Goel2, Shashank Purwar3

  • 1Forensic Medicine, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.

Cureus
|May 2, 2022
PubMed

Insights

This autopsy study found COVID-19 affects multiple organs, with viral RNA present in most. However, clinical findings did not correlate with lung or kidney histopathology, suggesting multifactorial mortality.

Area of Science:

  • Pathology
  • Virology
  • Internal Medicine

Background:

  • Coronavirus disease 2019 (COVID-19) has caused significant global mortality since 2019.
  • Understanding COVID-19's pathophysiology is crucial for managing its impact.

Purpose of the Study:

  • To investigate the pathophysiology of COVID-19 through autopsy.
  • To correlate histopathological and virological findings with clinical and biochemical data.

Main Methods:

  • Prospective observational autopsy study of 21 COVID-19 patients.
  • Histopathological grading of lung, liver, and kidney tissues.
  • Postmortem viral RNA detection using RT-PCR.
  • Correlation with antemortem clinical and biochemical data.

Main Results:

  • Multisystemic involvement observed in COVID-19 cases, with lung involvement in 90.4%.
  • Viral RNA detected in all organs studied, including liver (57.1%) and kidneys (66.6%).
  • Liver histopathology correlated with AST and ALT levels; no correlation found for lung/kidney histopathology with clinical scores or blood markers.

Conclusions:

  • COVID-19 is a multisystemic disease with multifactorial mortality.
  • Despite viral presence, clinical and histopathological findings showed limited correlation.
  • Hospitalization or ventilation duration did not correlate with lung histopathology severity.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
604
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
726
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
339
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
253